These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7569270)

  • 1. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?].
    LaRosa JC
    Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol lowering, low cholesterol, and mortality.
    LaRosa JC
    Am J Cardiol; 1993 Oct; 72(11):776-86. PubMed ID: 8213509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol and public policy.
    LaRosa JC
    Atherosclerosis; 1994 Aug; 108 Suppl():S137-41. PubMed ID: 7802720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol lowering and morbidity and mortality.
    LaRosa JC
    Curr Opin Lipidol; 1995 Feb; 6(1):62-5. PubMed ID: 7735718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies].
    Berger M
    Z Kardiol; 1993 Jul; 82(7):399-405. PubMed ID: 8379238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypercholesterolemia: to treat or not to treat? That is the question].
    Ducobu J
    Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
    Jost S; Lichtlen PR
    Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.
    Kronmal RA; Cain KC; Ye Z; Omenn GS
    Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol reduction therapy: a double-edged knife.
    Ong HT
    Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of lowering cholesterol on mortality].
    Schmidt JG
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2150-5. PubMed ID: 8266036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacoeconomic benefits of cholesterol reduction.
    Gonzalez ER
    Am J Manag Care; 1998 Feb; 4(2):223-30. PubMed ID: 10178493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.